Trial intelligence / Profile preview

Effects of Clopidogrel vs Prasugrel vs Ticagrelor on Endothelial Function in Coronary Stenting

NCT01700322Phase 4Completed

Sponsor
Johannes Gutenberg University Mainz
Start
Aug 2012
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor, prasugrel in coronary artery disease (CAD), sponsored by Johannes Gutenberg University Mainz. Started Aug 2012; status: completed.

02

Drugs

ticagrelorprasugrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01700322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01700322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call